Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
01/2012
01/04/2012CN101342155B (R,R)-formoterol inhalation dust cloud agent and preparation method thereof
01/04/2012CN101306098B Chinese medicinal materials orally taken for treating bronchiectasis hemoptysis
01/04/2012CN101301443B Decoction for treating phlegm-fire cough
01/04/2012CN101163677B Crystalline forms of a biphenyl compound
01/03/2012US8088934 Composition and method for stabilizing the same
01/03/2012US8088906 FAD4, FAD5, FAD5-2, and FAD6, novel fatty acid desaturase family members and uses thereof
01/03/2012US8088827 Use of irbesartan for the preparation of medicinal products that are useful for treating pulmonary hypertension
01/03/2012US8088780 5,7-disubstituted thiazolo[4,5-D]pyrimidines for the selective inhibition of chemokine receptors
01/03/2012US8088774 Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
01/03/2012US8088362 Salmeterol superfine formulation
01/03/2012CA2667566C Pyrazole analogs
01/03/2012CA2512434C Sustained-release pharmaceutical composition comprising carrageenan for lung administration
01/03/2012CA2506962C Synergistic combination comprising roflumilast and formoterol
01/03/2012CA2489128C 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
01/03/2012CA2488565C Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
01/03/2012CA2480423C Truncated 24 kda basic fibroblast growth factor
01/03/2012CA2468910C Use of 4-oxobutanoic acid derivatives in the treatment of inflammation
01/03/2012CA2465117C Lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases
01/03/2012CA2457719C Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
01/03/2012CA2395684C Sulfonamides and derivatives thereof that modulate the activity of endothelin
01/03/2012CA2362507C Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
12/2011
12/29/2011WO2011163518A1 Pyrazolo [1, 5 -a] pyrimidines as antiviral agents
12/29/2011WO2011163469A1 Hydrated form of anti-inflammatory roflumilast-n-oxide
12/29/2011WO2011162835A1 Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
12/29/2011WO2011162300A1 Crystal of fused pyridine compound salt
12/29/2011WO2011162274A1 Isoquinoline derivative
12/29/2011WO2011162222A1 Novel crystalline forms of 4,4'-[4-fluoro-7-({4-[4-(3-fluoro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1h-indole-1,3-diyl]dibutanoic acid, 4,4'-[2-methyl-7-({4-[4-(pentafluorophenyl)butoxy]phenyl}ethynyl)-1h-indole-1,3-diyl]dibutanoic acid, and 4,4'-[4-fluoro-2-methyl-7-({4-[4-(2,3,4,6-tetrafluorophenyl)butoxy]phenyl}ethynyl)-1h-indole-1,3-diyl]dibutanoic acid
12/29/2011WO2011161491A1 Methods and pharmaceutical compositions for the treatment of respiratory tract infections
12/29/2011WO2011161226A2 Novel antibody formulation
12/29/2011WO2011161018A1 Alkaloid aminoester derivatives and medicinal compositions thereof
12/29/2011WO2011160920A1 Dry powder formulation comprising an antimuscarinic drug
12/29/2011WO2011160919A1 Alkaloid aminoester derivatives and medicinal composition thereof
12/29/2011WO2011160918A1 Alkaloid aminoester derivatives and medicinal composition thereof
12/29/2011WO2011160632A1 Benzodioxole or benzodioxepine heterocyclic compounds phosphodiesterase inhibitors
12/29/2011WO2011160252A1 Organic acid salts of penehyclidine optical isomer
12/29/2011WO2011104301A3 Composition for treating dry cough and/or sore throat
12/29/2011WO2011097571A3 Methods for the use of progestogen as a glucocorticoid sensitizer
12/29/2011WO2011094749A3 Small molecule inhibitors that block assembly of the tgf-beta signaling complex
12/29/2011WO2011094504A3 Antimicrobial sinus irrigation compositions, methods, and devices
12/29/2011WO2011088474A3 Sulindac and sulindac derivatives and their uses related to infection
12/29/2011US20110319482 Novel treatments
12/29/2011US20110319475 Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf
12/29/2011US20110319453 Methods of Administering Pirfenidone Therapy
12/29/2011US20110319448 Guanidine-containing compounds useful as muscarinic receptor antagonists
12/29/2011US20110319446 Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses
12/29/2011US20110319445 Heteroaryl antagonists of prostaglandin d2 receptors
12/29/2011US20110319444 Quinuclidine carbonate salts and medicinal composition thereof
12/29/2011US20110319434 Bicyclic Heterocyclic Derivatives and Methods of Use Thereof
12/29/2011US20110319433 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treatment of inflammation
12/29/2011US20110319431 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors
12/29/2011US20110319420 Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinases inhibitor
12/29/2011US20110319410 Pyrazine derivatives and use as pi3k inhibitors
12/29/2011US20110319408 Methods of Treating Fibrosis, Cancer and Vascular Injuries
12/29/2011US20110319406 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors
12/29/2011US20110319405 Treatment and prevention of diffuse parenchymal lung disease by selective active-site mTOR inhibitors
12/29/2011US20110319402 Aerosol formulation for the inhalation of beta agonists
12/29/2011US20110319390 6-Aminoisoquinoline Compounds
12/29/2011US20110319371 Pharmaceutical formulations comprising 4-hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
12/29/2011US20110319363 Novel phosphonic acid compounds as inhibitors of serine proteases
12/29/2011US20110319350 Glycoside compounds and pharmaceutical compositions thereof
12/29/2011US20110319343 Agonists Of Guanylate Cyclase Useful For The Treatment Of Gastrointestinal Disorders, Inflammation, Cancer And Other Disorders
12/29/2011US20110319330 Methods For Treating Arthritis, Autoimmune Disease, and Ischemia-Reperfusion Injury
12/29/2011US20110319323 Pharmaceutical composition and method of use to improve organ function
12/29/2011US20110319318 Covalent milk protein/isothiocyanate complexes
12/29/2011US20110319317 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt1
12/29/2011US20110319316 Method for Preventing and Treating Hyperpermeability
12/29/2011US20110318393 Substituted Pyrazole Compounds
12/29/2011US20110318388 S1P Receptors Modulators and Their Use Thereof
12/29/2011US20110318353 Humanized IL-25 Antibodies
12/29/2011US20110318337 Humaneered anti-factor b antibody
12/29/2011CA2803459A1 Alkaloid aminoester derivatives and medicinal compositions thereof
12/29/2011CA2803433A1 Alkaloid aminoester derivatives and medicinal composition thereof
12/29/2011CA2803418A1 Dry powder formulation comprising an antimuscarinic drug
12/29/2011CA2803416A1 Alkaloid aminoester derivatives and medicinal composition thereof
12/29/2011CA2803159A1 New crystalline forms of 4,4'-[4-fluoro-7-({4-[4-(3-fluoro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1h-indole-1,3-diyl]dibutanoic acid, 4,4'-[2-methyl-7-({4-[4-(pentafluorophenyl)butoxy]phenyl}ethynyl)-1h-indole-1,3-diyl]dibutanoic acid, and 4,4'-[4-fluoro-2-methyl-7-({4-[4-(2,3,4,6-tetrafluorophenyl)butoxy]phenyl}ethynyl)-1h-indole-1,3-diyl]dibutano
12/29/2011CA2802895A1 Benzodioxole or benzodioxepine heterocyclic compounds phosphodiesterase inhibitors
12/29/2011CA2800834A1 Pyrazolo [1,5-a] pyrimidines as antiviral agents
12/29/2011CA2800206A1 Methods and pharmaceutical compositions for the treatment of respiratory tract infections
12/29/2011CA2788398A1 Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
12/28/2011EP2399604A1 Novel antibody formulation
12/28/2011EP2399599A2 Mucin hypersecretion inhibitors and methods of use
12/28/2011EP2399598A1 Blockade of CCL18 signaling via CCR6 as a therapeutic option in fibrotic diseases and cancer
12/28/2011EP2398798A1 Triazolopyridine derivatives as p38 map kinase inhibitors
12/28/2011EP2398792A1 Tosylate salt of a 5-pyrazolyl-2-pyridone derivative, useful in the treatment of copd
12/28/2011EP2398776A1 Functionally selective alpha2c adrenoreceptor agonists
12/28/2011EP2398772A1 5- (2-{ ý6- (2, 2-difluoro-2-phenylethoxy) hexyl¨amino}-l-hydroxyethyl) -8-hydroxyquin olin-2 (1h)-one and its use in the treatment of pulmonary diseases
12/28/2011EP2398473A1 5- (2-{ ý6- (2, 2-difluoro-2-phenylethoxy) hexyl¨amino} -1-hydroxyethyl) -8-hydroxyquinolin-2 (ih)-one for the treatment of lung function
12/28/2011EP1599221B1 Treatment of sinusitis related chronic facial pain and headache with botulinum toxin
12/28/2011CN102300870A 低分子量多硫酸化透明质酸衍生物和含有它的医药 Low molecular weight sulfated hyaluronic acid derivative and its pharmaceutical containing
12/28/2011CN102300865A 二聚的吡咯并嘧啶二酮和它在呼吸性疾病中的治疗用途 Dimeric pyrrolopyrimidine dione and its therapeutic use in respiratory diseases
12/28/2011CN102300572A 用于治疗气道疾病特别是哮喘的5-ht4抑制剂 For the treatment of airways diseases, particularly asthma 5-ht4 inhibitor
12/28/2011CN102300568A Hif-1蛋白积聚的抑制剂 Hif-1 protein accumulation inhibitor
12/28/2011CN102295637A 5-lipoxygenase-activating protein (FLAP) inhibitors
12/28/2011CN102294020A 空间构象改变的干扰素及其应用 Spatial conformational changes interferon and its Application
12/28/2011CN102294005A 一种足浴咳嗽剂 One kind of cough agent Foot
12/28/2011CN102293997A 一种干姜提取物的制备方法 A ginger extract preparation method thereof
12/28/2011CN102293992A 一种治疗放射性肺炎的中药 A treatment for radiation pneumonitis medicine
12/28/2011CN102293988A 一种治疗波尔山羊热喘症的中药制剂 A Boer goat hot breath of Chinese medicine treatment of disease
12/28/2011CN102293975A 一种治疗肺结核的药物及其制备方法 A tuberculosis drug treatment and its preparation method
12/28/2011CN102293973A 止咳片的制备方法 Preparation cough tablets